These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25168667)

  • 1. Neuropathic pain: precise sensory profiling improves treatment and calls for back-translation.
    Baron R; Dickenson AH
    Pain; 2014 Nov; 155(11):2215-2217. PubMed ID: 25168667
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study.
    Demant DT; Lund K; Vollert J; Maier C; Segerdahl M; Finnerup NB; Jensen TS; Sindrup SH
    Pain; 2014 Nov; 155(11):2263-73. PubMed ID: 25139589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voltage gated sodium and calcium channel blockers for the treatment of chronic inflammatory pain.
    Rahman W; Dickenson AH
    Neurosci Lett; 2013 Dec; 557 Pt A():19-26. PubMed ID: 23941888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Channelling treatment for neuropathic pain.
    Hayward P
    Lancet Neurol; 2005 Nov; 4(11):699. PubMed ID: 16265790
    [No Abstract]   [Full Text] [Related]  

  • 5. Sodium channel blockers in neuropathic pain.
    Kalso E
    Curr Pharm Des; 2005; 11(23):3005-11. PubMed ID: 16178759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and evidence for the use of oxcarbazepine in neuropathic pain.
    Carrazana E; Mikoshiba I
    J Pain Symptom Manage; 2003 May; 25(5 Suppl):S31-5. PubMed ID: 12694990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual Voltage-Gated Sodium Currents as Targets for Pain.
    Barbosa C; Cummins TR
    Curr Top Membr; 2016; 78():599-638. PubMed ID: 27586296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom-Based Treatment of Neuropathic Pain in Spinal Cord-Injured Patients: A Randomized Crossover Clinical Trial.
    Min K; Oh Y; Lee SH; Ryu JS
    Am J Phys Med Rehabil; 2016 May; 95(5):330-8. PubMed ID: 26368836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trigeminal neuralgia.
    Zakrzewska JM; Linskey ME
    BMJ; 2014 Feb; 348():g474. PubMed ID: 24534115
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of voltage-gated sodium channel blockers in the treatment of chronic pain: Potential uses in clinical practice based on available evidence.
    Alcántara Montero A; Sánchez Carnerero CI
    Rev Esp Anestesiol Reanim (Engl Ed); 2018 May; 65(5):275-283. PubMed ID: 29496230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coping with neuropathic pain: do we need more selective analgesic drugs?
    Mattia C
    Curr Pharm Des; 2005; 11(23):2941-3. PubMed ID: 16178754
    [No Abstract]   [Full Text] [Related]  

  • 12. Ion channel targets and treatment efficacy in neuropathic pain.
    Markman JD; Dworkin RH
    J Pain; 2006 Jan; 7(1 Suppl 1):S38-47. PubMed ID: 16427000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Discovery of voltage-gated sodium-channel blockers for the treatment of neuropathic pain].
    Watanabe S
    Nihon Yakurigaku Zasshi; 2012 Nov; 140(5):201-5. PubMed ID: 23138316
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoform selective voltage-gated sodium channel modulators and the therapy of pain.
    Jukič M; Kikelj D; Anderluh M
    Curr Med Chem; 2014; 21(2):164-86. PubMed ID: 24059240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating basic research on sodium channels in human neuropathic pain.
    Attal N; Bouhassira D
    J Pain; 2006 Jan; 7(1 Suppl 1):S31-7. PubMed ID: 16426999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voltage-gated sodium channel blockers: New perspectives in the treatment of neuropathic pain.
    Alcántara Montero A; Sánchez Carnerero CI
    Neurologia (Engl Ed); 2021 Mar; 36(2):169-171. PubMed ID: 32253051
    [No Abstract]   [Full Text] [Related]  

  • 17. Sodium channels and mechanisms of neuropathic pain.
    Devor M
    J Pain; 2006 Jan; 7(1 Suppl 1):S3-S12. PubMed ID: 16426998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies.
    Xiao W; Naso L; Bennett GJ
    Pain Med; 2008; 9(5):505-17. PubMed ID: 18777607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous lidocaine for neuropathic pain: diagnostic utility and therapeutic efficacy.
    Carroll I
    Curr Pain Headache Rep; 2007 Feb; 11(1):20-4. PubMed ID: 17214917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butyl 2-(4-[1.1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate, a potent sodium channel blocker for the treatment of neuropathic pain.
    Liberatore AM; Schulz J; Favre-Guilmard C; Pommier J; Lannoy J; Pawlowski E; Barthelemy MA; Huchet M; Auguet M; Chabrier PE; Bigg D
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1746-9. PubMed ID: 17234409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.